id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-336252-e92omqyr	Chen, Tracy Yixin	COVID‐19 pneumonia in kidney transplant recipients: Focus on immunosuppression management	2020-07-06		.txt	text/plain	1883	113	33	Over the course of follow‐up, 23 have been discharged home with a functioning allograft and in stable condition; 4 experienced acute kidney injury requiring renal replacement therapy; 7 patients were intubated, and 6 expired. CONCLUSION: Our findings described the characteristics and outcomes of this highly fatal illness in a multi‐ethnic kidney transplant cohort, with insights on immunosuppression management that could further our understanding of this unique disease in immunocompromised populations. 5 A brief correspondence on kidney transplant recipients hospitalized with COVID-19 pneumonia reported 35% mortality rate, withholding only antimetabolites primarily. Similarly, our results have shown that while all patients were taking immunosuppression prior to admission, their COVID infections uniformly advanced to moderate-to-severe disease with confirmed diagnosis of pneumonia, while seven of the 30 patients required intubation and 20% died, cautioning the use of immunosuppression especially during the earlier phase of infection when viral suppression by the immune system is key to halt disease progression. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management	./cache/cord-336252-e92omqyr.txt	./txt/cord-336252-e92omqyr.txt